Gao Yingying, Yang Jinrui, Zhang Xiaobei, Chen Aizhong, Gu Zhouhang, Du Zhiyou
College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Front Microbiol. 2021 Oct 22;12:760937. doi: 10.3389/fmicb.2021.760937. eCollection 2021.
The 2b proteins encoded by cucumber mosaic virus (CMV) subgroup I strains suppress RNA silencing primarily by competitively binding small RNAs (sRNAs) in the host cell cytoplasm. Interestingly, 2b proteins encoded by CMV subgroup II strains accumulate predominantly in nuclei. Here we determined that whereas the 2b protein (Fny2b) of subgroup IA strain Fny-CMV is highly effective in suppressing both sense RNA-induced and inverted repeat-induced posttranscriptional gene silencing, the 2b protein (LS2b) of the subgroup II strain LS-CMV was not as effective. Reducing nuclear accumulation of LS2b by mutating a residue in its nuclear localization sequence had no effect on RNA silencing suppressor activity, while attenuated viral symptoms. Electrophoretic mobility shift assays showed that the sRNA binding of LS2b was weaker and more selective than that of Fny2b. The domain determining the differential sRNA-binding ability was delimited to the putative helix α1 region. Moreover, LS2b mutants that completely lost suppressor activity still retained their weak sRNA-binding ability, suggesting that sRNA binding is not sufficient for LS2b to suppress RNA silencing. Considering the subgroup I strain-encoded 2b proteins that require sRNA-binding ability for the suppression of RNA silencing, we suggest that in addition to binding sRNA, the 2b proteins of subgroup II CMV strains would require extra biological activities to achieve RNA silencing inhibition.
黄瓜花叶病毒(CMV)亚组I毒株编码的2b蛋白主要通过在宿主细胞质中竞争性结合小RNA(sRNA)来抑制RNA沉默。有趣的是,CMV亚组II毒株编码的2b蛋白主要在细胞核中积累。在此,我们确定,虽然亚组IA毒株Fny-CMV的2b蛋白(Fny2b)在抑制正义RNA诱导的和反向重复序列诱导的转录后基因沉默方面都非常有效,但亚组II毒株LS-CMV的2b蛋白(LS2b)效果则没那么好。通过突变其核定位序列中的一个残基来减少LS2b的核积累,对RNA沉默抑制活性没有影响,但减轻了病毒症状。电泳迁移率变动分析表明,LS2b与sRNA的结合比Fny2b更弱且更具选择性。决定sRNA结合能力差异的结构域被限定在假定的α1螺旋区域。此外,完全丧失抑制活性的LS2b突变体仍保留其较弱的sRNA结合能力,这表明sRNA结合不足以使LS2b抑制RNA沉默。考虑到亚组I毒株编码的2b蛋白抑制RNA沉默需要sRNA结合能力,我们认为,除了结合sRNA外,亚组II CMV毒株的2b蛋白还需要额外的生物学活性来实现RNA沉默抑制。